Rasi To Ombudsman: No Risk Of Bias In EMA’s COVID-19 Drug Evaluations

 
• By Neena Brizmohun
  
Covid19_Pills
The EMA says it is ensuring independence in its evaluation of COVID-19 treatments and vaccines • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography